or
Bookmark and Share
Dithranol compositions for topical applications
   
Document Number
US Patent 4203969
Issued Date
May 20, 1980
Link
Inventors
Map
Abstract
Composition for topical application in the treatment of psoriasis comprises specified amounts of dithranol, an acid and anti-oxidant, petroleum jelly, which may be mixed with a spreadable synthetic rubber, water, and an emulsifier. These compositions show little tendency to spread after application to a psoriatic area and show a reduced tendency to stain.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
11
Comments:
no comments yet
Owner
Drythanol Limited (London,GB2)
Published
May 20, 1980
Application Number
05/900,861
Filed
April 28, 1978
US Classification
514/732  
Int'l Classification
A61K   31/05   (20060101)   A61K   47/06   (20060101)   A61K   31/045   (20060101)   A61K   47/32   (20060101)  
Priority Data
Jul 06, 1977 [GB] 28410/77
USPTO Field of Search
424/83   424/346  
Related Patents
4316902 - Therapeutic compositions and vehicles for topical pharmaceuticals

Non-sticky anhydrous bases useful as vehicles for cosmetics and therapeutic compositions to be topically applied are disclosed. The anhydrous base is composed of two essential ingredients namely isopropyl myristate or isopropyl palmitate and glyceryl monostearate in a concentration of more than 30% for the former by weight of the total composition. The base is excellent as a vehicle for cosmetics and also for pharmaceuticals to be topically applied in the treatment of skin disorders.

4495203 - Anhydrous composition, stable to oxidation, based on anthralin or one of its derivatives, in a carrier consisting of a fatty acid alkyl ester and a thickener, and its use in the treatment of skin diseases - Owned by Societe Anonyme dite: L'OREAL (Paris,FR)

Anhydrous composition, stable to oxidation, of anthralin or a derivative thereof. This composition contains anthralin or a derivative thereof in a carrier composed of (i) at least one fatty acid alkyl ester, the fatty acid having 12 to 18 carbon atoms and the alkyl radical having 2 or 3 carbon atoms, and (ii) at least one thickener taken from the group made up of silicas having particle sizes less than 30 m.mu. and polyethylene powders having densities between 0.9 and 0.96 (g/cm.sup.3). This composition is used in the treatment of skin diseases, particularly psoriasis.

5034420 - Compositions and method for stabilization of anthralin comprising the addition of an oil soluble antioxidant and an anionic surfactant - Owned by Bristol-Myers Squibb Co. (New York, NY)

This invention relates to an anthralin composition having improved stability. The invention further relates to a method for increasing the stability of anthralin in dermatological compositions by incorporating therein a stability enhancing amount of an acid stable anionic surfactant and a water soluble antioxidant.

6403123 - Method for topical treatment of anthralin-responsive dermatological disorders

The staining of skin and clothing incidental to the topical application of anthralin may be avoided or eliminated by: (a) topically applying an anthralin formulation containing a therapeutically effective amount of anthralin to the involved area of the skin; and (b) topically applying a wax formulation to the involved area, wherein the wax formulation comprises a wax. In addition, a powder may be topically applied to the involved area.

5407958 - Therapeutic skin composition - Owned by BeautiControl Cosmetics, Inc. (Carrollton, TX)

Therapeutic and preventive compositions that treat dull, dry and rough skin, improve skin smoothness and elasticity, diminish fine lines and wrinkles, prevent acne and promote renewed skin vibrance. The compositions include an alpha hydroxy acid and a preservative.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us